Dr. Desmond Hau obtained his M.Phil. in Biochemistry from The University of Hong Kong and Ph.D. in Research & Development Division of School of Chinese Medicine from Hong Kong Baptist University. He is the Chief Executive Officer of Pangenia Holdings Limited and also the Founder of Bio-Gene Technology Limited. Dr. Hau has more than 25 years of experience in marketing and management, specializing in scientific and clinical laboratory markets in Hong Kong, Macau and mainland China.

Dr. Hau has also served as External Grant Assessor at the Knowledge Transfer Office of City University of Hong Kong and was a member of the Faculty of Science Advisory Committee of Hong Kong Baptist University. Working with the School of Chinese Medicine of Hong Kong Baptist University, Dr. Hau developed and introduced a series of Chinese Medicinal health food products into the market through the branding “BU Health”.

Mr. Anthony Wong was trained in Medical Laboratory Sciences at the Institute of Pathology in Hong Kong and obtained a degree in Genetics and Biochemistry at University of Leeds UK and Master of Science in Clinical Chemistry at CUHK. He received post-graduate training in Cytogenetics at the Paediatric Research Unit at Guy’s Hospital in London. After he returned to Hong Kong, he took the position of Scientific Officer (Medical) at Tsan Yuk Hospital, where he led the laboratory team for prenatal diagnosis. With the great accomplishments, Mr. Wong was the Director of Medical Genetics Laboratory Limited in provision of prenatal genetic laboratory services. He also contributed an integral part in establishing the first non-hospital base assisted reproductive laboratory in Hong Kong.

Mr. Francis Tam is currently the Vice President of Pangenia Group and is in charge of Sales and Marketing Strategy. He is also board member of a few affiliates’ biotechnology companies in Hong Kong and China.

Mr. Tam studied Landscape Architecture and Civil Engineering at the University of California Davis and graduated with a Bachelor of Science (BSLA) there. He continued his studies at Hong Kong Polytechnic University, receiving his Master of Business Administration (MBA) and Executive Master of Innovation Leadership (EMIL).

Mr. Jones Lo has been the Group Financial Controller of Pangenia Group since April 2017 and has over 10 years of experience in corporate finance and audit. Before joining the Group in December 2015, he was a senior manager of KPMG. Mr. Lo received a Bachelor of Business Administration in Financial Services of The Hong Kong Polytechnic University in 2007. He is also an associate member of the Hong Kong Institute of Certified Public Accountants since September 2010.

Ms. Lucy Lai is the Director of Sales and Marketing of Pangenia Group. She leads a multinational team that strategizes and promotes our in-vitro diagnostics products to over 35 international markets (including Africa, Europe, Middle East, Latin America and Asia). She supports the development of new products with her in-depth market intelligence. She is also responsible for the launch of advance genetic tests that applies next-generation sequencing (NGS) to the local market.

Ms. Lai received her B.Sc. in Molecular Biotechnology, and M.Sc. in Marketing from The Chinese University of Hong Kong; and she obtained her MBA from Hong Kong University of Science and Technology.

Dr. Guo has over 15 years of solid experience in research and clinical laboratories. Previously, she worked as a Postdoctoral Visiting Fellow in National Institute of Environmental Health Sciences (NIEHS/NIH). She received her Ph.D at School of Biological Science of The University of Hong Kong, her M. Sc. at Department of Microbiology and Parasitology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, and her MBBS in Department of Clinical Medicine, Hebei Medical University. She published 12 journal articles and conference abstracts.